Who owns NUVECTIS PHARMA INC?
- Ticker: NVCT
- CUSIP Number: 67080t108
Tip: Access positions for across all investors
Analyze quarterly positions in Nuvectis Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nuvectis Pharma stock
Who bought or sold NUVECTIS PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Baldwin Brothers | 356k | $1.9M | 104% | Dec 2024 |
|
| Vanguard Group | 325k | $1.8M | 8% | Dec 2024 |
|
| Marshall Wace | 125k | $674k | 191% | Dec 2024 |
|
| Geode Capital Management | 79k | $429k | -1% | Dec 2024 |
|
| BlackRock | 62k | $337k | 26% | Dec 2024 |
|
| Paul Kendrigan | 59k | $319k | 22% | Dec 2024 |
|
| Susquehanna International | 46k | $247k | 72% | Dec 2024 |
|
| GSA Capital Partners | 35k | $188k | -31% | Dec 2024 |
|
| Qube Research & Technologies | 31k | $166k | 36% | Dec 2024 |
|
| Millennium Management | 30k | $161k | -57% | Dec 2024 |
|
| Northern Trust | 26k | $139k | 69% | Dec 2024 |
|
| Oppenheimer & Co | 25k | $135k | 100% | Dec 2024 |
|
| State Street Corporation | 22k | $119k | 44% | Dec 2024 |
|
| Squarepoint Ops | 19k | $103k | 100% | Dec 2024 |
|
| Two Sigma Investments | 19k | $101k | -31% | Dec 2024 |
|
| Edmond De Rothschild Holding | 15k | $82k | -21% | Dec 2024 |
|
| Baxter Brothers | 15k | $81k | 20% | Dec 2024 |
|
| Nations Financial Group | 14k | $73k | 35% | Dec 2024 |
|
| Cubist Systematic Strategies | 6.3k | $34k | 100% | Dec 2024 |
|
| Point72 Asia | 4.5k | $24k | 100% | Dec 2024 |
|
| UBS Group | 2.7k | $14k | 24164% | Dec 2024 |
|
| Morgan Stanley | 2.3k | $13k | -1% | Dec 2024 |
|
| Bank of America Corporation | 1.6k | $8.7k | 112% | Dec 2024 |
|
| Barclays | 1.1k | $6.0k | 0% | Dec 2024 |
|
| Hollencrest Securities | 400.00 | $2.2k | 43% | Dec 2024 |
|
| Jpmorgan Chase & Co | 179.00 | $967.996200 | -7% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 115.00 | $622.000500 | 100% | Dec 2024 |
|
| Steward Partners Investment Advisory | 100.00 | $541.000000 | 0% | Dec 2024 |
|
| Point72 | 49.00 | $265.001800 | 100% | Dec 2024 |
|
| Nbc Securities | 5.00 | $27.000000 | -98% | Dec 2024 |
|
Who sold out of Nuvectis Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Iridian Asset Management | Sep 2024 | 55k | $348k |
| Renaissance Technologies | Sep 2024 | 16k | $99k |
| Citigroup | Sep 2024 | 8.9k | $56k |
| Mirae Asset Global Etfs Holdings | Jun 2024 | 3.3k | $21k |
| Catalyst Funds Management Pty | Jun 2024 | 900.00 | $5.7k |
| Tower Research Capital | Sep 2024 | 588.00 | $3.7k |
| FMR | Sep 2024 | 402.00 | $2.5k |
| NISA Investment Advisors | Sep 2024 | 12.00 | $75.000000 |